Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AAP Implantate AG | AAQ1 | Apr 30, 2024 | 0.95 | +2.70 |
Advanced Medical Solutions Group | AQA | Apr 30, 2024 | 2.18 | -0.91 |
Ansell Ltd. | PD1A | Apr 30, 2024 | 15.30 | 0.00 |
Ansell Ltd. | PD1 | Apr 30, 2024 | 56.50 | 0.00 |
BATM Advanced Communications Limited | BAV | Apr 30, 2024 | 0.18 | -1.61 |
Bio-Gate AG | BIG1 | Apr 30, 2024 | 0.99 | +1.02 |
Braster S.A. | 7UD | Apr 30, 2024 | 0.09 | 0.00 |
Carl Zeiss Meditec A G | AFXA | Apr 30, 2024 | 97.50 | 0.00 |
Carmat | CXT | Apr 30, 2024 | 3.01 | -0.99 |
Cochlear Ltd. | OC5 | Apr 30, 2024 | 197.88 | -0.13 |
Cochlear Ltd. | OC50 | Apr 30, 2024 | 98.50 | +1.03 |
COLOPLAST AS ADR | CBH | Apr 30, 2024 | 11.50 | +0.88 |
ConvaTec Group plc American Depositary Receipts - Unsponsore | 2CVU | Apr 30, 2024 | 11.20 | -3.45 |
Creo Medical Group plc | 1RC | Apr 30, 2024 | 0.41 | 0.00 |
Crossject | 74C | Apr 30, 2024 | 1.92 | +0.74 |
Cyberdyne Inc | 8C4 | Apr 30, 2024 | 1.18 | +0.17 |
DMS | DMS1 | Apr 30, 2024 | 0.93 | -1.27 |
Elexxion AG | E8X | Apr 30, 2024 | 0.15 | 0.00 |
EssilorLuxottica American Depositary Receipts - Unsponsored | ESLC | Apr 30, 2024 | 99.50 | -1.49 |
Euromedis Groupe | 61R | Apr 30, 2024 | 4.64 | +1.31 |
Fisher & Paykel Healthcare Corporation Limited | FPLB | Apr 30, 2024 | 15.40 | +1.32 |
Genomtec S.A. | 4VI | Apr 30, 2024 | 2.44 | -2.00 |
HeraMED Limited | 1I4 | Apr 30, 2024 | 0.01 | 0.00 |
Hoya Corporation | HYB | Apr 30, 2024 | 109.35 | -1.58 |
Implanet | IM11 | Apr 30, 2024 | 0.06 | +0.66 |
Inspecs Group Plc | 4GV | Apr 30, 2024 | 0.58 | -1.68 |
Inspiration Healthcare Group Plc | LXD1 | Apr 30, 2024 | 0.35 | -3.35 |
Japan Medical Dynamic Marketing Inc. | JMD | Apr 30, 2024 | 3.92 | +1.03 |
JINS Holdings Inc. | 5F3 | Apr 30, 2024 | 19.40 | +2.11 |
Kangji Medical Holdings Limited | 50J | Apr 30, 2024 | 0.84 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.